Gynaecology drugs
24 results
Annovera (segesterone acetate and ethinyl estradiol)
(segesterone acetate and ethinyl estradiol)TherapeuticsMD, Inc.
Usage: ANNOVERA is indicated for pregnancy prevention in females of reproductive potential. However, it has not been sufficiently studied in those with a BMI greater than 29 kg/m².
Balcoltra (levonorgestrel and ethinyl estradiol)
(levonorgestrel and ethinyl estradiol)Avion Pharmaceuticals
Usage: Balcoltra is indicated for females of reproductive potential for the prevention of pregnancy.
Intrarosa (prasterone)
(Prasterone)Millicent US, Inc.
Usage: INTRAROSA® is indicated for the treatment of moderate to severe dyspareunia, a symptom associated with vulvar and vaginal atrophy due to menopause.
Kyleena (levonorgestrel)
(Levonorgestrel)Bayer HealthCare Pharmaceuticals Inc.
Usage: Kyleena is indicated for the prevention of pregnancy for up to 5 years. It should be replaced after this period if continued use is desired.
Liletta (levonorgestrel)
(Levonorgestrel)Allergan, Inc.
Usage: LILETTA is indicated for contraception to prevent pregnancy for up to 8 years and for the treatment of heavy menstrual bleeding in patients choosing intrauterine contraception, effective for up to 5 years, with replacement needed thereafter if continued treatment is required.
Lupron depot (leuprolide acetate)
(leuprolide acetate)AbbVie Inc.
Usage: LUPRON DEPOT 11.25 mg is indicated for managing endometriosis (pain relief and lesion reduction) and, when combined with norethindrone acetate, for symptom management. It also prepares women with anemia due to uterine fibroids for surgery, enhancing hematologic improvement alongside iron therapy. Total therapy duration should not exceed 12 months.
Myfembree (relugolix, estradiol hemihydrate, and norethindrone acetate)
(relugolix, estradiol hemihydrate, and norethindrone acetate)Sumitomo Pharma America, Inc
Usage: MYFEMBREE is indicated for managing heavy menstrual bleeding associated with uterine leiomyomas and moderate to severe pain related to endometriosis in premenopausal women. Use should be limited to 24 months due to potential irreversible bone loss.
Natazia (estradiol valerate and estradiol valerate/dienogest)
(estradiol valerate and estradiol valerate/dienogest)Bayer HealthCare Pharmaceuticals Inc.
Usage: Natazia® is indicated for use as an oral contraceptive to prevent pregnancy and for the treatment of heavy menstrual bleeding in women without organic pathology who prefer an oral contraceptive method. Its efficacy in women with a BMI > 30 kg/m² has not been evaluated.
Nextstellis (drospirenone and estetrol)
(drospirenone and estetrol)Mayne Pharma
Usage: NEXTSTELLIS is indicated for pregnancy prevention in females of reproductive potential. Its effectiveness may be reduced in those with a BMI of 30 kg/m² or higher, with decreased effectiveness correlating with increasing BMI.
Nuvaring (etonogestrel and ethinyl estradiol)
(etonogestrel and ethinyl estradiol)Organon LLC
Usage: NuvaRing® is indicated for vaginal use in females of reproductive age for the prevention of pregnancy.